Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2004
06/23/2004CN1507493A Biosynthetic genes for butenyl-spinosyn insecticide production
06/23/2004CN1507492A P18A betar P gene and P18A beta r p protein, novel gene/protein (P60 TRP) interacting therewith to inhibit cell death and cell death promoter
06/23/2004CN1507452A Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides
06/23/2004CN1507354A Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists
06/23/2004CN1506880A Sequence display method and homologous searching method for convenient for accessing relative information to mutation zone and similar zone among multi-sequence
06/23/2004CN1506467A SCAR marker linked with the acidic character of peach fruit and its application
06/23/2004CN1506466A Method and kit for amplifying nucleic acid of target cell or virus
06/23/2004CN1506463A Method for yeast cell to express human interleukin 10
06/23/2004CN1506462A Phosphoenolpyruvate carboxylase, its encoding gene and the application of the gene
06/23/2004CN1506461A Heat-resisting xylanase and gene coding the xylanase
06/23/2004CN1506457A Production process of mycosis-resisting rice variety
06/23/2004CN1506454A Saccharomycetes containing large-scale salmon growth factor
06/23/2004CN1506377A Human granulocyte-macrophage colony stimulating factor/interleukin-6 fusion protein and its construction process
06/23/2004CN1506376A Embedded CD25-resisting monoclonal antibody and its coding sequence and application
06/23/2004CN1506375A Azurin as bacterial protein with wide-spectrum antitumor function and its use and medicinal composition
06/23/2004CN1154747C Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretrioviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
06/23/2004CN1154745C Method of utilizing antisense gene in controlling protein and oil content of seed
06/23/2004CN1154744C Retroviral vectors that containing none of viral coding sequences
06/23/2004CN1154743C Amphotropic retrovirus packaging cell line, process for its production and use thereof
06/23/2004CN1154742C Recombinant MVA virus, and the use thereof
06/23/2004CN1154741C Chimera gene with serveral herbicide resistant genes, plant cell and plant resistant to serveral herbicides
06/23/2004CN1154740C Root cortex specific gene promoter
06/23/2004CN1154739C System for mass production of proteins or prptides by microorganisms of genus humicola
06/23/2004CN1154738C Noval method for characterization of compounds which stimulate STF-1 expression in pancreatic islet cells
06/23/2004CN1154737C Transgenic plants with altered senescence characteristics
06/23/2004CN1154736C Methods and compositions for secretion of heterologous polypeptides
06/23/2004CN1154735C Mammalian gene encoding tolloid protein
06/23/2004CN1154734C Mutated 5-enol pyruvylshikimate-3-phosphate sythase, gene coding for said protein and transformed plants containing said gene
06/23/2004CN1154733C Improved heat-stable DNA polymerase
06/23/2004CN1154732C Synthetic HPV6/11 hybrid Li DNA encoding human papliomavirus type 11 L1 protein
06/23/2004CN1154731C Gene of hop latent virus and methods for detecting the same
06/23/2004CN1154730C Compounds and methods for diagnosis of tuberculosis
06/23/2004CN1154729C Staphylokinase derivs
06/23/2004CN1154728C Method for leading-in petunia transcription factor Pet SPL 2 gene to shorten inflorescence internode
06/23/2004CN1154727C Recombinant expression vector of human parathyroid hormone using phosphoribulokinase as fusion partner
06/23/2004CN1154726C OB protein derivatives having prolonged half-life
06/23/2004CN1154725C Human bikunin
06/23/2004CN1154724C Human cholesterol ester synthtase-1 gene promoter 1
06/23/2004CN1154723C Floral organ-specific genes and promoter sequences thereof
06/23/2004CN1154722C Biological synthetic gene II of boitin
06/23/2004CN1154721C Enzyme endoglucanase and cellulase preparations containing the same
06/23/2004CN1154720C Beta-fructofuranosidase and gene thereof
06/23/2004CN1154717C Improved immortalized human skin cell lines and novel serum-free medium useful for prodn. thereof
06/23/2004CN1154716C L-isoleucine-producing bacterium and method for preparing L-isoleucine through femrentation
06/23/2004CN1154715C Microbial agricultural chemical
06/23/2004CN1154660C Hybrid molecules between heat-labile enterotoxin and cholera toxic B subunits
06/23/2004CN1154658C Process for the purification of glycoproteins like erythropoietin
06/23/2004CN1154414C Virus-resistant plant cells and process for constructing same
06/23/2004CA2415062A1 Methods and genetic sequences for modulating tuber formation in tuber-producing plants, and plants genetically modified to alter tuber size and number
06/22/2004US6753463 Transformed cotton plants
06/22/2004US6753462 Transgenic plants with increased calcium stores
06/22/2004US6753461 Method for increasing stress-resistance to a plant
06/22/2004US6753460 Methods and genetic compositions to limit outcrossing and undesired gene flow in crop plants
06/22/2004US6753459 Genetic construct comprising a conditionally lethal gene operably associated with promoter functional in plant cell, gene being used to select, identify or selectively kill a plant expressing said gene
06/22/2004US6753458 Process for obtaining transgenic leguminous plants (leguminosae) containing exogenous DNA
06/22/2004US6753457 Activation of fetal nucleus; obtain cells, separate nucleus, incubate with activating egg extract, monitor fetal nucleus activity
06/22/2004US6753456 Animal model for use in developing treatment for nicotine addiction and epilepsey
06/22/2004US6753424 Conjugates of DNA interacting groups with steroid hormones for use as nucleic acid transfection agents
06/22/2004US6753423 For preferentially modulated gene expression in liver and associated tissues
06/22/2004US6753421 Probes for the detection of mycobacteria
06/22/2004US6753419 Used for somatic gene therapy
06/22/2004US6753417 Peptide for use in the diagnosis and prevention of immunological and infectious disorders
06/22/2004US6753416 Modifications of the VEGF receptor-2 protein and methods of use
06/22/2004US6753412 Human Eag2
06/22/2004US6753324 Phosphorous organic compounds and their use
06/22/2004US6753321 Method of modulating neovascularization
06/22/2004US6753314 Protein-protein complexes and methods of using same
06/22/2004US6753313 Multimeric Apoa-I agonist compounds
06/22/2004US6753183 Immunologically active proteins from Borrelia burgdorferi
06/22/2004US6753176 Genetic engineering; antiarthritic agents
06/22/2004US6753175 Antiinflammatory agents; anticancer agents; cardiovascular disorders; genetic engineering; transgenic animals
06/22/2004US6753171 For controlling membrane denaturation reactions without physical shear force
06/22/2004US6753167 Preparation of heterologous proteins on oil bodies
06/22/2004US6753166 Nucleotide sequences coding polypeptides for use in the treatment of inflammatory and autoimmune diseases
06/22/2004US6753164 Nucleic acids encoding human serpin polypeptide HMCIS41
06/22/2004US6753161 Optoinjection methods
06/22/2004US6753156 Homogeneous method for detecting and/or determining phosphorylating activity in a biological material
06/22/2004US6753153 Markers for identification and isolation of pancreatic islet α and β progenitors
06/22/2004US6753149 For producing vaccines for the prevention or attenuation of infection by staphylococcus
06/22/2004US6753148 Methods and apparatus for detecting variants utilizing base stacking
06/22/2004US6753147 Digital amplification
06/22/2004US6753146 System and method for evaluating agents which prevent oxidative damage
06/22/2004US6753140 Nucleotide sequences coding preferential polypeptide for use in the treatment of diabetes and eating disorders
06/22/2004US6753139 For screening for the occurrence of gene silencing (e.g., post transcriptional gene silencing) in an organism
06/22/2004US6753137 Diagnosing stomach cancer in humans; obtain fluid sample, detect epstein barr virus, the presence of the virus is an indication of stomach cancer
06/22/2004US6753136 Expressing preferential amino acid sequences on surface of viruses; obtain genetically engineered viruses, express amino acid sequences, moniltor viral coat for presence of preferential amino acid sequences
06/22/2004US6752994 Microorganismal cell model for use as tool in treatment of tuberculosis, skin disorders and infections
06/22/2004US6752992 Bacillus endotoxin for controlling moths; cry proteins
06/22/2004US6752991 Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor
06/22/2004US6752987 Adenovirus encoding human adenylylcyclase (AC) VI
06/22/2004CA2210620C Anti-cd 30 antibodies preventing proteolytic cleavage and release of membrane-bound cd 30 antigen
06/22/2004CA2164672C Process for purifying hepatitis b viral surface antigen comprising pres2 peptide
06/22/2004CA2118760C Diagnosis and monitoring of colon cancer patients by measurement of nca 50/90 in blood
06/22/2004CA2118759C Diagnosis and monitoring of lung cancer patients by measurement of nca 50/90 in blood
06/22/2004CA2110702C Process for the production of a viable cell culture infected by a multiple sclerosis associated virus
06/22/2004CA2059554C Fetal cell recovery method
06/22/2004CA2049429C Dna sequencing
06/20/2004CA2453872A1 Heat-labile desoxyribonuclease i variants
06/20/2004CA2453723A1 Method for increasing protein content in plant cells
06/19/2004CA2423904A1 Haplotype partitioning in the proximal promoter of the human growth hormone (gh1) gene